All News

NKx

FDA RMAT Designation Granted to Fate Therapeutics for FT516 Treatment of Relapsed/Refractory DLBCL
16 December 2021
FDA RMAT Designation Granted to Fate Therapeutics for FT516 Treatment of Relapsed/Refractory DLBCL
News
Strategic Manufacturing Partnership Announced Between Gates Biomanufacturing Facility and Nkarta
6 October 2021
Strategic Manufacturing Partnership Announced Between Gates Biomanufacturing Facility and Nkarta
News
Next-Generation CAR-T, Car-M and NK/NKT Platform Launched, Focussed on Curing Difficult-To-Treat Cancers
16 June 2021
Next-Generation CAR-T, Car-M and NK/NKT Platform Launched, Focussed on Curing Difficult-To-Treat Cancers
Inceptor Bio has announced the
Research Collaboration Seeks to Optimise Dual-Targeted NK Cell Therapy Against Acute Myeloid Leukaemia
26 May 2021
Research Collaboration Seeks to Optimise Dual-Targeted NK Cell Therapy Against Acute Myeloid Leukaemia
A new research agreement, funded
POPULAR NEWS ITEMS
Image
22 September 2022

CAR-T Manufacturing Challenges and How to Overcome Them

Image
22 September 2022

Lentiviral Vector Manufacture and Testing: Challenges and Solutions

Image
22 September 2022

Looking to the Future of CAR-T Cell Therapy Manufacture

Enabling Next Generation Cell Therapies with GMP-Grade Human iPSCs
3 March 2021
Enabling Next Generation Cell Therapies with GMP-Grade Human iPSCs
Are induced pluripotent stem cells
Harnessing the Power of the Innate Immune System Using NK Cells
8 January 2019
Harnessing the Power of the Innate Immune System Using NK Cells
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

CAR-T Manufacturing Challenges and How to Overcome Them

Image

Lentiviral Vector Manufacture and Testing: Challenges and Solutions

Image

Looking to the Future of CAR-T Cell Therapy Manufacture